19.09.2018
- With its pending $425-million acquisition of Halo Pharmaceuticals, Cambrex joins other contract providers that have used acquisitions in recent years to build end-to-to end service...
04.06.2018
- Wolfgang Wienand has been appointed as new CEO of Siegfried with effect from Jan. 1, 2019. Rudolf Hanko, the group’s current CEO, will step down on Dec. 31, 2018. The board has...
12.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
06.12.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
08.09.2016
- Despite tremendous challenges facing the pharmaceutical industry, it continues with its commitment to innovation and the discovery of novel drugs to address unmet medical needs...
13.06.2016
- Since the beginning of the 21st century, pharma M&A activity has exploded. Mergers and acquisitions, layoffs, and outsourcing of research and manufacturing have become common place...
04.04.2016
- In September of 2015, Siegfried completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the German group’s active pharmaceutical...
25.09.2015
- Siegfried Holding, the Swiss drug contract manufacturer, said it has completed all closing conditions for its acquisition of the custom synthesis business of BASF and parts of the...
